Clinical trial
Unfractioned Heparin for Treatment of Sepsis
NCT00100308 · Universidad de Antioquia, Other · Completed
Key facts
| NCT number | NCT00100308 |
|---|---|
| Title | Unfractioned Heparin for Treatment of Sepsis |
| Official title | Unfractioned Heparin for Treatment of Sepsis: A Randomized Clinical Trial (The HETRASE Study) |
| Lead sponsor | Universidad de Antioquia, Other |
| Collaborators | Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sepsis, Bacterial Infections |
| Intervention type | Drug |
| Interventions | Unfractioned heparin, saline |
| Enrollment | 319 |
| Start date | Jul 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Dec 29, 2004 |
| Last update posted | Jan 15, 2008 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: